| Financial Year |
March 31 2023 |
| Monetary Funds |
482,799,271.01 |
| Held-for-trading Financial Assets |
4,602,000.00 |
| Notes Receivable |
150,012.00 |
| Accounts Receivable |
661,620,442.69 |
| Advances to Suppliers |
339,648,968.37 |
| Other Receivables |
331,778,956.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,783,369.25 |
| Inventories |
3,482,297,292.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,977,815.79 |
| Total Current Assets |
5,328,874,758.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
259,477,269.11 |
| Investment Properties |
13,548,176.12 |
| Fixed Assetes |
6,296,408,770.31 |
| Under-construction Projects |
1,104,799,342.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
906,634,867.68 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
622,026,538.11 |
| R&D expenses |
-- |
| Goodwill |
439,171,178.64 |
| Long-Term Deferred and Prepaid Expenses |
353,518,884.94 |
| Deferred Income Tax Assets |
308,151,175.07 |
| Other Non-Current Assets |
488,792,467.21 |
| Sub-Total of Non-Current Assets |
13,226,397,666.67 |
| Total Assets |
18,555,272,425.30 |
| Short-Term Loans |
3,844,475,552.93 |
| Trading Financial liabilities |
88,266,981.70 |
| Notes Payable |
546,635,974.95 |
| Accounts Payable |
3,679,500,954.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
192,494,467.44 |
| Taxes Payable |
36,750,847.36 |
| Interest Payable |
-- |
| Dividend Payable |
17,083,433.80 |
| Other payables |
1,107,632,688.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,233,996,225.37 |
| Other Current Liabilities |
716,219.45 |
| Sub-Total of Current Liabilities |
12,101,971,574.34 |
| Long-term Loans |
1,347,167,083.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
273,739,457.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
952,175.08 |
| Deferred Income Tax Liabilities |
69,039,231.45 |
| Other Non-Current Liabilities |
1,907,318.16 |
| Sub-Total of Non-Current Liabilities |
3,321,059,475.74 |
| Total Liabilities |
15,423,031,050.08 |
| Paid-In Capital(Or Share Stock) |
871,058,222.00 |
| Capital Surplus |
3,497,109,154.67 |
| Surplus Reserve |
68,356,991.56 |
| LESS:Treasury Stock |
81,901,118.60 |
| Undistributed Profits |
-2,152,764,303.36 |
| Minority Stockholder's Interest |
973,601,717.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,158,639,657.36 |
| Owner's Equity（Stockholder's Equity） |
3,132,241,375.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,555,272,425.30 |
